Work

The Impact of Late Luteinizing Hormone-Releasing Hormone Agonist Dosing on Testosterone Suppression in Patients with Prostate Cancer: An Analysis of United States Clinical Data

Year: 2019

Type: article

Study design: Observational Study

Source: The Journal of Urology

DOI: 10.1097/ju.0000000000000577

Authors: E. David Crawford, Przemyslaw W. Twardowski, Raoul S. Concepcion, Jason M. Hafron, Richard G. Harris, Judd W. Moul, Lucio N. Gordan, Daniel P. Petrylak, Stuart N. Atkinson, Deborah M. Boldt-Houle, Thomas E. Keane, Celestia S. Higano, R. Jonathan Henderson, A. Karim Kader, Maha H. Hussain, Neal D. Shore

Institutions: University of California San Diego, Michigan Institute of Urology, Duke University, Yale University, Medical University of South Carolina, University of Washington, Regional Urology, Northwestern University

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2978083517

FWCI: 1.321

Cites:

Cited by: 14

Related to: 10